Skip to main content
Premium Trial:

Request an Annual Quote

TwinStrand Biosciences: Gary Gilliland

Gary Gilliland has been appointed to the board of directors of Seattle-based TwinStrand Biosciences. Until February 2020, he was the president and director of the Fred Hutchinson Cancer Research Center. Prior to that, he was a professor at Harvard Medical School, director of the leukemia program at the Dana-Farber Cancer Institute, senior VP and global oncology franchise head at Merck, and vice dean of the Perlman School of Medicine at the University of Pennsylvania. Gilliland holds an MD from the University of California, San Francisco, and a PhD in microbiology from the University of California, Los Angeles.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.